IP Library Granted Patent US 9,597,010
Granted Patent B2
US 9,597,010 · App. 14/260,196 · Granted Mar 21, 2017

Communication system using an implantable device

Inventors: Todd Thompson (San Jose, CA); Mark Zdeblick (Portola Valley, CA); Yashar Behzadi (Anaheim, CA); Benedict Costello (Piedmont, CA); Timothy Robertson (Belmont, CA); Hooman Hafezi (Redwood City, CA); George Savage (Portola Valley, CA)
Assignee: Proteus Digital Health, Inc.
A61B5/076A61B5/0028A61B5/073A61B5/14539A61J3/007G06F19/3418H01Q1/273A61B5/4839A61B2560/0214A61N1/37288
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,597,010
App. No.
14/260,196
Granted
Mar 21, 2017
Kind
B2
Abstract

The system of the present invention includes an implantable device that can detect high and low frequency current signature. The implantable device can communicate with a communication device that includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, the communication device is activated.

Claims (39)

1. An ingestible device to communicate information, the ingestible device comprising:

a support structure;

a first material physically associated with the support structure; and

a second material physically associated with the support structure at a location different from a location of the first material, wherein the second material is dissimilar from the first material and has a different electrochemical potential such that the first and second materials produce a voltage potential difference as a result of the first and second materials being in contact with an electrically conductive fluid; and

a control device coupled to the first and second materials and powered by the voltage potential difference produced by the first and second materials when the first and second materials are in contact with the electrically conductive fluid, wherein the control device is configured to produce a first current signature comprising first information, which is conducted along a first current path formed by the electrically conductive fluid, the first material, and the second material, and wherein the control device is configured to produce a second current signature which is conducted along a second current path formed by the electrically conductive fluid, the first material, and the second material;

wherein the first information includes programming instructions to program an implantable device.

2. The ingestible device of claim 1 , further comprising a memory coupled to the control device.

3. The ingestible device of claim 2 , wherein the memory stores program information to program the control device to output the first or second current signatures.

4. The ingestible device of claim 2 , further comprising a receiver system coupled to the control device and the memory, wherein the receiver system is configured to receive program information and store the received program information in the memory.

5. The ingestible device of claim 4 , wherein the received program information is configured to program the control device to output the first and second current signatures.

6. An ingestible device to communicate first and second information, the ingestible device comprising:

a support structure;

a first material physically associated with the support structure; and

a second material physically associated with the support structure at a location different from a location of the first material, wherein the second material is dissimilar from the first material and has a different electrochemical potential such that the first and second materials produce a voltage potential difference as a result of the first and second materials being in contact with an electrically conductive fluid;

a control module coupled to the first and second materials to control the conductance between the first material and the second material, wherein when the first and second materials are in contact with the electrically conductive fluid, the voltage potential difference is to power the control module and cause the control module to produce a first current signature which contains the first information, and wherein the first current signature is conducted along a current path formed by the electrically conductive fluid, the first material, and the second material; and

a communication unit coupled to the first and second materials to communicate the second information, wherein when the first and second materials are in contact with the electrically conductive fluid, the voltage potential difference is configured to power the communication unit and cause the communication unit to communicate the second information.

7. The ingestible device of claim 6 , wherein the communication unit is configured to function as any one of a receiver, a transmitter, or a transceiver.

8. The ingestible device of claim 7 , wherein the communication unit is configured to receive or transmit the second information in the form of a second current signature conducted through the electrically conductive fluid surrounding the ingestible device.

9. The ingestible device of claim 8 , wherein the communication unit is configured to receive the second information from a receiver attached to a user's body, a device being held by the user, or an implanted device, any one of which is configured to generate the second current signature through the user's body.

10. The ingestible device of claim 8 , wherein the second current signature includes the second information that is encoded therein.

11. The ingestible device of claim 10 , wherein the communication unit and the control module are configured to detect the second current signature and to decode the second current signature to receive the second information.

12. The ingestible device of claim of claim 6 , wherein the communication unit is configured to receive the second information either wirelessly or through transconduction to control activation of the ingestible device.

13. The ingestible device of claim 6 , further comprising at least one sensor to monitor environmental conditions surrounding the ingestible device, wherein when the environmental conditions become favorable for communication, as determined by measurements of the environmental conditions from the at least one sensor, the communication unit sends a signal to the control module to alter the conductance between the first and second materials to allow for communication using the first current signature.

14. An ingestible device to communicate information, the ingestible device comprising:

a first material; and

a second material dissimilar from the first material and having a different electrochemical potential such that the first and second materials produce a voltage potential difference as a result of the first and second materials being in contact with an electrically conductive fluid; and

a control device coupled to the first and second materials and powered by the voltage potential difference produced by the first and second materials when the first and second materials are in contact with the electrically conductive fluid, wherein the control device is configured to produce a first current signature and a second current signature that are conducted along a current path formed by the electrically conductive fluid, the first material, and the second material;

wherein the first current signature comprises first information; and

wherein the second current signature comprises second information;

wherein the first information includes programming instructions to program an implantable device.

15. The ingestible device of claim 14 , wherein the control device is configured to control conductance between the first and second materials.

16. The ingestible device of claim 14 , wherein the control device is configured to alter the conductance between the first and second materials to encode the first and second information in the first and second current signatures, respectively.

17. The ingestible device of claim 14 , wherein the first current signature is encoded to identify the ingestible device.

18. The ingestible device of claim 14 , wherein the second current signature is encoded to communicate with an implantable device.

19. An ingestible device to communicate information to an implantable device, the ingestible device comprising:

a first material; and

a second material dissimilar from the first material and having a different electrochemical potential such that the first and second materials produce a voltage potential difference as a result of the first and second materials being in contact with an electrically conductive fluid; and

a control device coupled to the first and second materials and powered by the voltage potential difference produced by the first and second materials, wherein the control device is configured to produce a first current signature and a second current signature; and

wherein the first current signature is a very low current state that maintains an oscillator and the second current signature is a current state at least a factor of ten higher than the very low current state associated with the first current signature.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2024
From: PROTEUS DIGITAL HEALTH INC.,
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 068980/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2024
From: OTSUKA AMERICA PHARMACEUTICAL, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 068980/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2014
From: THOMPSON, TODD; ZDEBLICK, MARK; BEHZADI, YASHAR; COSTELLO, BENEDICT; ROBERTSON, TIMOTHY; HAFEZI, HOOMAN; SAVAGE, GEORGE
To: PROTEUS BIOMEDICAL, INC.
Reel/Frame 033352/0261 →
CHANGE OF NAME Recorded Jul 21, 2014
From: PROTEUS BIOMEDICAL, INC.
To: PROTEUS DIGITAL HEALTH, INC.
Reel/Frame 033371/0471 →
Continuity (2)
Continuation 13180539 · Jul 11, 2011
Related Publication 20150080677A1 · Mar 19, 2015